Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pigmentary Glaucoma Patients”

457 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 457 results

Not applicableUnknownNCT05466526
What this trial is testing

Microinvasive Glaucoma Surgery -The Lowering Effect of Intraocular Pressure on Glaucoma Patients With High Frequency Deep Sclerotomy

Who this might be right for
Primary Open Angle GlaucomaIntraocular PressureGlaucoma Surgery
National Taiwan University Hospital Hsin-Chu Branch 30
Not applicableStudy completedNCT04461249
What this trial is testing

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients

Who this might be right for
Primary Open Angle Glaucoma
Kasr El Aini Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01915940
What this trial is testing

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 169
Large-scale testing (Phase 3)Study completedNCT05973318
What this trial is testing

Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

Who this might be right for
Primary Open Angle Glaucoma of Both Eyes
Jadran Galenski laboratorij d.d. 110
Post-approval studies (Phase 4)Study completedNCT00800540
What this trial is testing

Circadian Ocular Perfusion Pressure and Ocular Blood Flow

Who this might be right for
Glaucoma
Alcon Research 35
Not applicableActive Not RecruitingNCT07154810
What this trial is testing

Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

Who this might be right for
GlaucomaCataractOcular Hypertension
SpyGlass Pharma, Inc. 23
Not applicableStudy completedNCT01632423
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 10,337
Large-scale testing (Phase 3)Study completedNCT00928590
What this trial is testing

Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 155
Not applicableStudy completedNCT01840202
What this trial is testing

Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study

Who this might be right for
Open Angle GlaucomaNormal Tension Glaucoma
Universitaire Ziekenhuizen KU Leuven 770
Post-approval studies (Phase 4)Study completedNCT01327599
What this trial is testing

Efficacy of Changing to DUOTRAV® From Prior Therapy

Who this might be right for
Open-Angle GlaucomaOcular HypertensionPigment Dispersion Glaucoma
Alcon Research 60
Not applicableStudy completedNCT01068964
What this trial is testing

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Allergan 235
Not applicableEnrolling By InvitationNCT06230393
What this trial is testing

An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

Who this might be right for
Open Angle GlaucomaIntraocular Pressure
New World Medical, Inc. 20
Post-approval studies (Phase 4)Study completedNCT03104621
What this trial is testing

Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients

Who this might be right for
Primary Open-angle Glaucoma
Gangnam Severance Hospital 20
Not applicableUnknownNCT00854256
What this trial is testing

Trabeculectomy Versus Canaloplasty to Treat Glaucoma

Who this might be right for
Glaucoma
University of Cologne 60
Not applicableStudy completedNCT01767753
What this trial is testing

IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty

Who this might be right for
Primary Open Angle GlaucomaPigmentary GlaucomaPseudoexfoliative Glaucoma
Sensimed AG 23
Large-scale testing (Phase 3)Study completedNCT00159653
What this trial is testing

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500
Large-scale testing (Phase 3)Study completedNCT00047541
What this trial is testing

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research
Large-scale testing (Phase 3)Study completedNCT00288951
What this trial is testing

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 690
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Post-approval studies (Phase 4)Ended earlyNCT06407973
What this trial is testing

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma

Who this might be right for
Primary Open Angle Glaucoma
Sight Sciences, Inc. 2
Load More Results